Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support

SpeciesReishi, Lingzhi

JournalRecent patents on anti-cancer drug discovery

Year2025

Metadata-grounded summary

Article summary

Metadata-grounded summary: This journal article indexes research on Ganoderma lucidum in Recent patents on anti-cancer drug discovery in 2025. MycoData maps the paper to oncology, immune support, metabolic health, liver support based on its title, species context, article metadata, and study classification.

Citation

Jiang B, Li N, Du W, Zeng L, Tang Y, Luo L, et al. (2025). Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study. Recent patents on anti-cancer drug discovery https://doi.org/10.2174/0115748928282946240111114448 PMID: 38385492

Open citation